AgNOR polymorphism association with squamous intraepithelial lesions and invasive carcinoma with HPV infection;Asociación de los polimorfismos AgNORs con lesiones intraepiteliales escamosas, carcinoma cervical e infección por VPH

Salud Publica de Mexico

Volumn 51, Issue 2, 2009, Pages 134-140

  Alarcón Romero, Luz del Carmen ^a,c   Illades Aguiar, Berenice ^a   Flores Alfaro, Eugenia ^a   Terán Porcayo, Marco Antonio ^b   Antonio Véjar, Verónica ^a   Reyes Maldonado, Elba ^c  

^a UNIVERSIDAD AUTÓNOMA DE GUERRERO   (Mexico)

^b Arturo Beltrán Ortega ^*  (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Carcinoma; Human papillomavirus; Mexico; Nucleolar organizer regions; Squamous cell; Squamous intraepithelial lesions

Indexed keywords

ADULT; AGED; ALPHAPAPILLOMAVIRUS; ARTICLE; CHROMOSOME NOR; CLASSIFICATION; DISEASE COURSE; DNA PROBE; FEMALE; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; SILVER STAINING; SQUAMOUS CELL CARCINOMA; ULTRASTRUCTURE; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; DNA PROBES, HPV; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; NUCLEOLUS ORGANIZER REGION; PAPILLOMAVIRUS INFECTIONS; SILVER STAINING; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS; YOUNG ADULT;

EID: 67650139113     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/S0036-36342009000200009     Document Type: Article

References (40)

1. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2(5):342-350.
2. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-841.
3. Lazcano-Ponce EC, Rascon-Pacheco RA, Lozano-Ascencio R, Velasco-Mondragón HE. Mortality from carcinoma of the uterine cervix in Mexico: impact of screening 1980-1990. Acta Cytol 1996;40:506-512.
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
5. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87:796-802.
6. Franco EL, Villa LL, Ruiz A, Costa MC. Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. J Infect Dis 1995;172:756-763.
7. Kjellberg L, Hallmans G, Ahren AM, Johansson R, Bergman F, Wadell G, et al. Smoking, diet, pregnancy, and oral contraceptive use as risk factors for cervical intraepithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 2000;82:1332-1338.
8. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst (Bethesda) 1993;85:958-964.
9. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, et al. A cohort study of the risk of cervical cancer intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992: 327:1272-1278.
10. Egan M, Freeth M, Crocker J. Intraepithelial neoplasia, human papillomavirus infection and argyrophilia nucleoprotein in cervical epithelium. Histopathology 1988;13: 561-567.
11. Cardillo MR. AgNOR counts are useful in cervical smears. Diagn Cytopathol 1992;8:208-210.
12. Crocker J, Boldy AR, Egan MJ. How should we count AgNORs? Proposal for a standardized approach. J Pathol 1989;158:185-188.
13. Rocher AE, Gonzalez A, Palaoro LA, Blanco AM. Usefulness of AgNOR technique and CEA expression in atypical metaplastic cells from cervical smears. Anal Quant Cytol Histol 2006;28:130-136.
14. Misra JS, Das V, Srivastava AN, Singh U, Singh M. AgNOR counts in cervical smears under normal and other cytopathologic conditions. Anal Quant Cytol Histol 2005;27:337-340.
15. Singh M, Prasad S, Kalra N, Singh U, Shukla Y. Silver-Stained Nucleolar Organizer Regions in normal and and dysplastic cervical lesions: Correlation with DNA ploidy and S-phase fraction by flow cytometry. Oncol 2006;71:411-416.
16. Agarwal J, Gupta JK. Nucleolar organizer regions in neoplastic and non-neoplastic epithelium of the cervix. Indian J Pathol Microbiol 1997;40:125-127.
17. Calore EE, Maeda MYS, Cavaliere MJ. Study of nucleolar organizer regions by the argyrophil technique in cervical intraepithelial neoplasia. Minerva Ginecol 1997;49:59-62.
18. +-NORs in cervical smears from women with cervical cancer. Analyt Quant Cytol Histol 2001; 23:9-14.
19. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994;174:1077-1085.
20. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ. Improvement in the staining and in the visualization of the argyrophilic protein of the nucleolar organizer region at the optical level. Histochem J 1986;18:5-14.
21. Verduzco-Rodriguez L, Palet-Guzmán JA, Aguirre-González H, González-Puebla E. Cáncer cervico-uterino y edad. Ginecol Obstet Mex 1997; 5:119-122.
22. Lazcano-Ponce E, Herrero R, Muñoz N, Cruz A, Shah KV, Alonso P, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001;91:412-420.
23. Sasagawa T, Basha W, Yamazaki H, Inouse M. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 2001;10:45-52.
24. Van der Graaf Y, Molijn A, Doornewaard H, Quint W, Van Doorn LJ, Van Den Tweel J. Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 2002;156:158-164.
25. Schellekens MC, Dijkman A, Aziz MF, Siregar B, Cornain S, Kolkman-Uljee S, et al. Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia. Gynecol Oncol 2004;93:49-53.
26. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527.
27. Giuliano AR, Papenfuss M, Abrahamsen M, Denman C, de Zapien JG, Henze JL, et al. Human papillomavirus infection at the United States-Mexico border: Implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev 2001;10:1129-1136.
28. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider A, et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1999;59:6132-6136.
29. th International Papillomavirus Conference, July 2000.
30. Ordoñez-Razo RM, Mendoza-Alcantár L, Reynoso-Pablos R, Solorzano-Luna G, Ramírez-Gaytán JL, Meneses-García A, et al. Papilomavirus humano en pacientes con cáncer cervicouterino en el Instituto Nacional de Cancerología. Rev Inst Nal Cancerol 1993;39:1809-1813.
31. Hernández-Avila M, Lazcano-Ponce EC, Berumen-Campos J, Cruz-Valdéz A, Alonso de Ruíz PP, González-Lira G, et al. Human papillomavirus 16-18 infection and cervical cancer in Mexico: a case-control study. Arch Med Res 1997;28:265-71.
32. Khanna AK, Giri AK, Khanna A, Kumar M. Nucleolar organizer region count and subjective AgNOR pattern assessment (SAPA) score in skin tumors. J Sur Oncol 2001;78:273-278.
33. Dervan PA, Gilmartin L, Loftus BM, Carney DN. Breast carcinoma kinetics. Argyrophilic nucleolar organizer region counts correlate with Ki67 score. Am J Clin Pathol 1989;92:401-407.
34. Cabrini RL, Schwint AE, Mendez A, Femopase F, Lanfranchi H, Itoiz ME. Morphometric study of nucleolar organizer regions in human oral normal mucosa, papilloma and squamous cell carcinoma. J oral Pathol Med 1992;21: 275-279.
35. Rowlands DC. Nucleolar organising regions in cervical intraepithelial neoplasia. J Clin Pathol 1988;41:1200-1202
36. Calore EE, Maeda MY, Cavaliere MJ, Pereira SM, Shih LW, Pereira GM, et al. Study of organizer nucleolar regions by the argyrophil technique in cervical intraepithelial neoplasias. Minerva Ginecol 1997;49:59-62.
37. Pelusi G, Trerè D, Formelli G, Rinaldi AM, Derenzini M. AgNOR protein quantity of cervical smears correlates with that of histological sections in cervical intraepithelial neoplasia. Eur J Histochem 1997;41:105-110.
38. Prathiba D, Kuruvilla S. Value of AgNORs in premalignant and malignant lesions of the cervix. Indian J Pathol Microbiol 1995;38: 11-16.
39. Palaoro LA, Blanco AM, Gamboni M, Rocher AE, Rotenberg RG. Usefulness of ploidy AgNOR and immunocytochemistry for differentiating benign and malignant cells in serous effusions. Cytopathol 2007;18:33-39.
40. Thickett KM, Griffin NR, Griffiths AP, Wells M. A study of nucleolar organizer in cervical intraepithelial neoplasia and human papillomavirus infection. Am J Obstet Gynecol 1989;8:331-339.